Boxer Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.1M Buy
3,983,000
+2,808,000
+239% +$17.2M 3.32% 8
2026
Q1
$8.99M Buy
1,175,000
+425,000
+57% +$3.25M 1.18% 23
2025
Q4
$7.29M Sell
750,000
-300,000
-29% -$2.55M 1.6% 19
2025
Q3
$4.4M Sell
1,050,000
-1,161,341
-53% -$7.42M 1.4% 19
2025
Q2
$20.5M Buy
2,211,341
+415,000
+23% +$3.62M 10.34% 3
2025
Q1
$17.5M Hold
1,796,341
5.27% 7
2024
Q4
$21.8M Buy
+1,796,341
New +$21.8M 1.85% 14

Other funds holding REPL

Boxer Capital Management's REPL Position: Q2 2026 in Review

Boxer Capital Management increased its Replimune Group (REPL) stake by 239% in Q2 2026, buying an estimated $17.2M and bringing the position to 3,983,000 shares worth $44.1M. The position accounts for 3.32% of the portfolio, ranked #8.

Boxer Capital Management first reported a position in REPL in Q4 2024 and has held it in 7 quarters since. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Boxer Capital Management held 3,983,000 shares of Replimune Group worth $44.1M as of Q2 2026.
  • Boxer Capital Management bought 2,808,000 Replimune Group shares in Q2 2026, an estimated $17.2M.
  • Replimune Group made up 3.32% of Boxer Capital Management's portfolio in Q2 2026, its #8 holding.
  • Boxer Capital Management first reported a position in Replimune Group in Q4 2024 and has held it in 7 quarters since.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Boxer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.